Printer Friendly

CardioVations Announces Next in Line of Innovative Heart Stabilization Systems; Device Gives Surgeons Precision and Control during Heart Bypass Surgery.

SOMERVILLE, N.J., April 20 /PRNewswire/ -- CardioVations, a division of ETHICON, announced today the latest advancement to their line of heart stabilization systems. The EMBRACE* Heart Stabilizer stabilizes desired areas of the heart, which in turn, creates a relatively stationary coronary artery during beating heart or "off-pump" coronary bypass (OPCAB) surgery and gives cardiac surgeons confidence for the most demanding procedures. The device uses stabilization "feet" to hold in place the epicardium parallel to the coronary artery in place, allowing them to bypass the blocked artery without resorting to the traditional method of stopping the heart and employing the heart/lung machine.

This new device builds on the innovative standards set by the predecessor device, FLEXSITE* Heart Stabilizer. The new EMBRACE stabilizer provides surgeons extreme confidence for the most demanding off-pump coronary artery bypass (OPCAB) procedures, with a 360-degree rotation and tilt for optimal visualization and access to lateral wall vessels. The malleable foot pods allow for custom contouring to the epicardial surface and the low-profile suction pods gently spread tissue at the anastomotic site. The redesigned low-profile stabilizer arm provides for quick, one-step stabilization and control with a unique activation lever. This simple, single-hand activation lever provides control to fine-tune adjustments and positioning.

"For patients undergoing coronary revascularization, off-pump surgery has been shown to be beneficial," stated Valavanur Subramanian, MD, Director, Department of Surgery, Lenox Hill Hospital, New York, NY. "Devices such as the EMBRACE stabilizer allow for complete revascularization during an off-pump procedure and are valuable additions to the ongoing development of beating heart surgery."

It is estimated that the "off-pump" method of coronary bypass is used in 25% of all coronary bypass surgeries.(1) Allowing the patient's own lungs and heart to maintain circulation rather than artificial components has been shown to be beneficial to patients.

The surgeon should not position the stabilizer foot pods over a coronary artery, or over newly infarcted or aneurysmal heart tissue. Physicians should be adequately trained and have familiarity with less invasive cardiac surgical procedures. They should consult medical literature relative to techniques, complications, and hazards prior to performance of any cardiac surgical procedure. Many variables, including patient anatomy, pathology and surgical techniques may influence procedural outcomes. As with any surgical procedure, there are risks associated with heart surgery using these devices. Risks associated with this procedure are typical of those associated with conventional coronary artery surgery.

About CardioVations

CardioVations, a division of ETHICON, INC., a Johnson & Johnson Company, is a pioneer in cardiovascular surgery devices that reduce complications and improve outcomes for patients. CardioVations offers innovations in the areas of off-pump coronary artery bypass grafting (CABG), valve surgery, anastomotic devices and vessel management. Additional information on CardioVations can be found at
 * Trademark

 (1) Medtech Insight, Novel Connections in Bypass Surgery, May 2002.


 Amy Firsching

CONTACT: Amy Firsching, +1-908-218-2783,

Web site:
COPYRIGHT 2004 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 20, 2004
Previous Article:Stepan Announces First Quarter Earnings Conference Call and Webcast.
Next Article:30% Discount on 1st Class One-Way Thalys Tickets for Summer Travel Between France-Belgium-Netherlands-Germany.

Related Articles
A-Med Systems Announces Alliance with Baxter Healthcare for Distribution of New Circulatory Support System.
Medtronic Announces the Worldwide Launch of Four New Cardiac Surgery Products, Including the Octopus(R)3 Tissue Stabilization System.
Genzyme Surgical Products Receives Clearance to Market Innovative Valve Implantation System.
Novare Signs Exclusive U.S. Distribution Pact With CardioVations For Enclose(R) in Cardiac Surgery; Century Medical to Offer Novare's Surgical...
FDA Clears Novare's Enclose(R) II Anastomotic Assist Device for Multiple-Vessel Heart Bypass Surgery; Bypass Attachment Device Offers Surgeons...
Novare Signs International Distribution Pact With Medtronic for Enclose II(R) in Cardiac Surgery; Deal Provides Novare Global Access to Cardiac...
CardioVations Announces Introduction of Innovative Heart Stabilization System; Devices Represent a Major Advance in Precision and Control during...

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters